000 01146 a2200337 4500
005 20250516200632.0
264 0 _c20150218
008 201502s 0 0 eng d
022 _a1468-3288
024 7 _a10.1136/gutjnl-2014-306746
_2doi
040 _aNLM
_beng
_cNLM
100 1 _avan Bodegraven, Ad A
245 0 0 _aAuthors' response: The role of risedronate in osteopenia in Crohn's disease.
_h[electronic resource]
260 _bGut
_cJan 2015
300 _a185-6 p.
_bdigital
500 _aPublication Type: Letter; Comment
650 0 4 _aBone Density Conservation Agents
_xtherapeutic use
650 0 4 _aBone Diseases, Metabolic
_xdrug therapy
650 0 4 _aCalcium
_xtherapeutic use
650 0 4 _aCrohn Disease
_xcomplications
650 0 4 _aDietary Supplements
650 0 4 _aEtidronic Acid
_xanalogs & derivatives
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aVitamin D
_xtherapeutic use
700 1 _aWitte, Birgit I
700 1 _aLips, Paul
773 0 _tGut
_gvol. 64
_gno. 1
_gp. 185-6
856 4 0 _uhttps://doi.org/10.1136/gutjnl-2014-306746
_zAvailable from publisher's website
999 _c23585381
_d23585381